Mehra Uneek
Known title: Chief Financial OfficerCIK: 0001881504
Associated companies
Transaction History
| BBOT | ▼ Sell | Tax Withholding | 524 | $5K | 4/1/2026 | View on chart |
| BBOT | ▲ Buy | Grant | 23,330 | $0 | 3/10/2026 | View on chart |
| BBOT | ▼ Sell | Tax Withholding | 524 | $5K | 4/1/2026 | View on chart |
| BBOT | ▲ Buy | Grant | 23,330 | $0 | 3/10/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
BBOT reports inducement grants under Nasdaq Rule 5635(c)(4)
BridgeBio Oncology Therapeutics announced that it has reported inducement grants in accordance with Nasdaq Listing Rule 5635(c)(4). The disclosure confirms the company’s compliance with regulatory reporting requirements for incentive arrangements. While the announcement does not provide details on the size of the grants, it highlights ongoing governance practices.
BBOT reports inducement grants under Nasdaq Rule 5635(c)(4). BridgeBio Oncology Therapeutics announced that it has reported inducement grants in accordance with Nasdaq Listing Rule 5635(c)(4). The disclosure confirms the company’s compliance with regulatory reporting requirements for incentive arrangements. While the announcement does not provide details on the size of the grants, it highlights ongoing governance practices.